How can the cellular immune response control hepatitis B virus replication?

Journal of Viral Hepatitis

Volumn 7, Issue 5, 2000, Pages 321-326

  Maini, ^a   Bertoletti, ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CTL; HBV; Multispecificity; Viral control

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA A2 ANTIGEN; VIRUS ANTIGEN; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B VIRUS; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; VIRUS MUTATION; VIRUS REPLICATION;

HEPATITIS B; HEPATITIS B VIRUS; HUMANS; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 0033822021     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2000.00234.x     Document Type: Review

References (54)

1. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen
2. Hepatitis B virus persistence after recovery of acute viral hepatitis
3. Long-lasting memory T cell responses following self-limited acute hepatitis B
4. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response
5. Occult hepatitis B virus as a source of infection in liver transplant recipients
6. Hepatitis B virus and hepatitis B related viral infection in renal transplant recipients
7. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis
8. Cytotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen
9. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection
10. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
11. Direct ex vivo analysis of hepatitis B specific CD8(+) T cells associated with the control of infection
12. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection
13. Hepatitis B virus immunopathogenesis
14. In a small multideterminant peptide, each determinant is recognised by a different Vβ gene segment
15. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
16. Defence by diversity
17. HLA and HIV-1: Heterozygote advantage and B*5-Cw*04 disadvantage
18. Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection
19. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I associated myelopathy
20. Analysis of a successful immune response against hepatitis C virus
21. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope
22. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection
23. Genomic variations in the hepatitis B virus core gene: A possible factor influencing response to interferon alfa treatment
24. Precore mutations and core clustering mutations in chronic hepatitis B virus infection
25. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis
26. Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection
27. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes
28. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
29. + T-helper and a T-killer cell
30. + T cells
31. Viral immune evasion due to persistence of activated T cells without effector function
32. IL-12: Initiation cytokine for cell-mediated immunity
33. Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice
34. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B
35. Cellular immune response to hepatitis B virus encoded antigens in acute and chronic hepatitis B virus infection
36. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B
37. + T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants
38. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virus
39. Acute exacerbation of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion
40. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B
41. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen
42. Heterozygote advantage for HLA-class II type in hepatitis B virus infection
43. Host genetic factors influencing the outcome of hepatitis
44. Vertical transmission of hepatitis B antigen in Taiwan
45. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: A mechanism for persistence
46. Is a function of the secreted hepatitis B e antigen to induce Immunotolerance in vivo?
47. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
48. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans
49. Viral strategies of immune evasion
50. Immune response of peripheral blood mononuclear cells to HBx antigen of hepatitis B virus
51. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid
52. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen
53. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection
54. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis